← back to search

David Couper

University of North Carolina at Chapel Hill · US
Area of research
Pulmonary and Respiratory Medicine · Rheumatology
Research interest
Dr. David Couper's faculty appointment is in the Collaborative Studies Coordinating Center (CSCC), a unit in the Department of Biostatistics. Dr. Couper has worked at the CSCC since 1998 and has been the coordinating center (CC) Principal Investigator for several clinical trials and observational studies. He is currently PI of the Coordinating Center for the Atherosclerosis Risk in Communities (ARIC) Study, the ARIC Neurocognitive Study (ARIC-NCS), and the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) and the Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn’s Disease (CAMEO clinical trials, as well as the PI of the Genomics and Informatics Center for the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
h-index
105
citations
44,174
works
886
NIH funding
primary concept
Medicine
email

Recent publications

Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma
Clinical Chemistry 2025cited by 17position: middledoi
Hearing Intervention, Social Isolation, and Loneliness
JAMA Internal Medicine 2025cited by 10position: middledoi
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma.  Rooney MR, Chen J, Ballantyne CM, Hoogeveen RC, Boerwinkle E, Yu B, Walker KA, Schlosser P, Selvin E, Chatterjee N, Couper D, Grams ME, Coresh J.  (2025).  Clin Chem, 71 (6), 677–87.
2025cited by 0position: selected
Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men
Annals of Internal Medicine 2024cited by 65position: middledoi
Epidemiologic Features of Recovery From SARS-CoV-2 Infection
JAMA Network Open 2024cited by 51position: middledoi
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine 2024cited by 27position: middledoi
Vessel and Airway Characteristics in One-Year Computed Tomography–Defined Rapid Emphysema Progression: SPIROMICS
Annals of the American Thoracic Society 2024cited by 12position: middledoi
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS
American Journal of Respiratory and Critical Care Medicine 2024cited by 9position: middledoi
Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema
American Journal of Respiratory and Critical Care Medicine 2024cited by 8position: middledoi
Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2024cited by 6position: middledoi
Phenotypes and Trajectories of Tobacco-Exposed Persons with Preserved Spirometry: Insights from Lung Volumes
Annals of the American Thoracic Society 2024cited by 4position: middledoi
Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial
The Lancet 2023cited by 407position: middledoi
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
JAMA 2023cited by 41position: middledoi
Factors Associated With Circulating Sex Hormones in Men
Annals of Internal Medicine 2023cited by 38position: middledoi
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans
Thorax 2023cited by 36position: middledoi
Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine 2023cited by 33position: middledoi
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD
Scientific Reports 2023cited by 13position: middledoi
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts
Annals of the American Thoracic Society 2023cited by 11position: middledoi
Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study
Journal of Thrombosis and Haemostasis 2023cited by 8position: middledoi
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine 2022cited by 92position: middledoi
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study
American Journal of Respiratory and Critical Care Medicine 2022cited by 45position: middledoi
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study
European Heart Journal 2022cited by 35position: middledoi
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2022cited by 34position: middledoi
Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima‐Media Thickness: An Individual Participant Data Meta‐Analysis
Journal of the American Heart Association 2022cited by 27position: middledoi
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
CHEST Journal 2022cited by 16position: middledoi
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR
The Science of The Total Environment 2022cited by 14position: middledoi
Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort
Journal of the Academy of Consultation-Liaison Psychiatry 2022cited by 12position: middledoi
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
CHEST Journal 2022cited by 12position: middledoi
The ARIC (Atherosclerosis Risk In Communities) Study
Journal of the American College of Cardiology 2021cited by 517position: middledoi
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults
JAMA 2021cited by 272position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Prescott G. Woodruff · Advanced ENT and Allergy30 papers (2013–2024)MeiLan K. Han · Seoul National University Hospital28 papers (2013–2024)Fernando J. Martínez · University of Massachusetts Chan Medical School26 papers (2013–2024)Nadia N. Hansel · Johns Hopkins Bayview Medical Center26 papers (2014–2024)Robert Paine · University of Utah25 papers (2015–2024)R. Graham Barr · La Trobe University24 papers (2013–2024)Richard E. Kanner · University of Utah23 papers (2013–2024)Eric A. Hoffman · Roy J. Carver Charitable Trust22 papers (2013–2024)Christopher B. Cooper · Johns Hopkins University22 papers (2016–2024)Eugene R. Bleecker · University of Arizona21 papers (2013–2023)Stephen I. Rennard · Anna Needs Neuroblastoma Answers18 papers (2013–2024)Jeffrey L. Curtis · VA Ann Arbor Healthcare System16 papers (2014–2024)Mark T. Dransfield · University of Minnesota Morris15 papers (2016–2024)Jerry A. Krishnan · IIT Research Institute13 papers (2016–2024)Alejandro P. Comellas · University of Iowa13 papers (2016–2024)Russell P. Bowler · University of Alabama at Birmingham12 papers (2017–2024)Stephen P. Peters · Johns Hopkins University12 papers (2014–2024)Igor Barjaktarević · University of California, Los Angeles10 papers (2019–2024)Wanda K. O’Neal · University of North Carolina at Chapel Hill10 papers (2014–2022)Eric C. Kleerup · University of California, Los Angeles9 papers (2013–2019)